{
    "laboratory_examinations": [
        {
            "procedure_name": "Blood Pressure Measurement",
            "date": "Not specified",
            "findings": "BP values ranged from 160/110 to 180/120 mm Hg",
            "changes_over_time": "Initially normal BP values were reported 1 year earlier; BP normalized after treatment"
        },
        {
            "procedure_name": "Biochemical Profile",
            "date": "Not specified",
            "findings": "Hypokalemia: 2.6 mmol/L, Low renin: 5.4 pg/mL, Undetectable aldosterone",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Urinary THFs to THE Ratio",
            "date": "Not specified",
            "findings": "Ratio: 8.91",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Biochemical Profile (Younger Brother)",
            "date": "Not specified",
            "findings": "Hypokalemia: 3.28 mmol/L, Low renin, Undetectable aldosterone, THFs to THE ratio: 6.1",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Follow-up Biochemical Measurements (1-year follow-up)",
            "date": "Not specified",
            "findings": "Normal BP and normal serum potassium concentrations",
            "changes_over_time": "Partial regression of LVH at echocardiography"
        },
        {
            "procedure_name": "HSD11B2 Promoter Methylation",
            "date": "Not specified",
            "findings": "Mean methylation index: 2.85% at region 1 and 7.37% at region 2",
            "changes_over_time": "Hypertensive heterozygous subjects showed higher methylation than those without hypertension"
        }
    ]
}